1 year return (CAGR)
-99.98%
Salarius Pharmaceuticals Inc Exchange (NASDAQ, USD)
SLRX
-
+0.01 (+1.28%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
915.58K
Price/Sales
51.17
Ent value
2.34M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.83 |
| Daily high | 0.92 |
| Daily low | 0.83 |
| Daily Volume | 571K |
| 1y analyst estimate | 26.00 |
| Beta | 0.40 |
| EPS (TTM) | -10.39 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| SLRX | S&P500 | |
| Current price drop from All-time high | -100.00% | -0.32% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 4 Dec 2025 | 9 Mar 2009 |
| Avg drop from high | -100.00% | -10.68% |
| Avg time to new high | - | 12 days |
| Max time to new high | 290 days | 1805 days |
News
No items found